Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HHIPL1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
mRNA | SFTA2 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
mRNA | MPC1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
mRNA | NEU3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | IL1RN | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
mRNA | ARHGAP11A | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
mRNA | BOC | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
mRNA | RNF145 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
mRNA | RP11-96O20.4 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
mRNA | SP4 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |